Elevance Health Inc. stock rallies 3.30% to $356.13, outperforming competitors

12 articles · Updated · MarketWatch · Apr 27

Elevance Health Inc. shares closed at $356.13 on Monday, with trading volume reaching 2.4 million, above its 50-day average of 1.9 million.
The stock outperformed UnitedHealth Group, which fell 0.06%, and Cigna Group, which rose 2.52%, while Humana gained 3.90%.
Despite the rally, Elevance Health remains 16.70% below its 52-week high of $427.54 set on April 28, amid a mixed session for major US indices.

Despite a stock surge, why are company insiders selling more shares of Elevance Health than buying?

Is Elevance Health's $1B AI investment a cure for rising costs or a future regulatory headache?

Can the high-growth Carelon unit truly offset the deep margin pressures in Elevance's Medicaid business?

Why does a DCF model value Elevance at $1,010 when analysts target only the $380 range?

After its New York acquisition, does Elevance now hold too much power over long-term care patients?

With CMS sanctions looming, is Elevance's rosy financial forecast built on a foundation of risk?